Specific medications help to prevent this long-term risk, but adherence to these agents is often suboptimal among patients. The study, published in Stroke, demonstrates the importance of medication ...
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH) Among 4,353 patients, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results